Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacology of TDF-FTC Pre-exposure Prophylaxis in Kenyan Cisgender Women
NCT05057858Phase 2Completed
- Sponsor
- University of Washington
- Start
- Apr 2022
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tenofovir disoproxil fumarate, emtricitabine in human immunodeficiency virus infection (HIV), sponsored by University of Washington. Started Apr 2022; status: completed.
02
Drugs
tenofovir disoproxil fumarateemtricitabine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT05057858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05057858.